Industry Experts

Allen Shen, is a seasoned biotech leader with over 18 years of research and 10 years of industry experience in neurobiology, RNA therapeutics, and gene therapy. He has led cross-functional teams in developing AAV vectors, antibody-oligonucleotide conjugates, and CNS-targeted delivery platforms. Allen has advanced over a dozen therapeutic programs through preclinical stages, built international innovation centers, and secured strategic partnerships. He is the founder of XAIgene Biotech and established biotech R&D settings, driving innovation in neurodegenerative and other diseases treatment. With deep scientific and operational expertise, Allen specializes in translating cutting-edge research into impactful, patient-focused therapies.